ESG in pharmaceutical quality assurance requires careful judgement about where quality responsibilities meet wider business expectations. Environmental, social and governance considerations can affect supplier selection, operational improvements and the evidence requested by customers. QA teams have useful skills to contribute, but their role needs to be defined alongside sustainability, procurement, engineering and legal colleagues.
Annex 1 contamination control now demands sustained attention beyond the initial implementation project. The revised EU GMP Annex 1 came into operation on 25 August 2023, with paragraph 8.123 following on 25 August 2024. For manufacturers in 2026, the useful question is whether the controls established during implementation still reflect the facility, its processes
A pharmaceutical quality decision is only as reliable as the evidence behind it. A result may meet its specification, but QA also needs to understand how that result was generated, whether it was changed and whether the complete record supports the conclusion. In 2026, pharmaceutical audit trails deserve attention because digital workflows can make
Traditional pharmaceutical manufacturing has historically been associated with scale. Large batches are manufactured, tested and released for thousands or millions of patients. Precision medicine is helping to change that model. Some emerging therapies target increasingly defined patient populations. Others, particularly advanced therapies, may involve extremely small manufacturing campaigns or even patient-specific material. That shift
Efficiency and compliance are sometimes presented as competing priorities in pharmaceutical manufacturing. One side wants faster processes, less paperwork and lower costs. The other wants controls, documentation and assurance. That is an increasingly outdated way of looking at quality. A mature Pharmaceutical Quality System should be capable of improving efficiency while protecting patients and
Outsourcing has become an established part of modern pharmaceutical manufacturing. Drug developers may depend on Contract Manufacturing Organisations (CMOs), Contract Development and Manufacturing Organisations (CDMOs), testing laboratories, packaging specialists, logistics providers and raw-material suppliers spread across multiple countries. The advantages are significant. Outsourcing can provide specialist expertise, additional manufacturing capacity, access to advanced technologies
Electronic Quality Management Systems have become central to the way pharmaceutical organisations manage deviations, CAPAs, change controls, audits, training, documentation and other critical quality processes. Yet the more important an eQMS becomes to an organisation, the more complicated upgrading it can become. What may appear to be a straightforward software project can quickly become
Quality Assurance sits at the heart of pharmaceutical manufacturing. Every medicinal product that reaches a patient must be manufactured, tested, documented, stored and released according to strict quality and regulatory requirements. Behind those processes are Quality Assurance professionals helping to ensure systems remain compliant, risks are controlled and product quality is consistently maintained. One
Quality Assurance has always played a critical role within the pharmaceutical industry. Today, however, the demands placed on QA professionals are evolving rapidly. Pharmaceutical manufacturing is becoming more technologically advanced, regulatory expectations continue to develop, and Quality Systems are increasingly expected to support risk-based decision-making, digitalisation and continual improvement. For QA professionals considering their
The pharmaceutical industry has never been more global. Active pharmaceutical ingredients may be manufactured in one country, processed in another, packaged elsewhere and ultimately supplied to multiple markets. Yet while pharmaceutical supply chains continue to become more interconnected, the regulatory environments governing them do not always move at the same speed. International initiatives such
